Psoriasis Clinical Trial

Use of Telemedicine to Address ‘Off Target’ Symptoms in Psoriatic Arthritis (PsA)

Summary

This will be a single-arm interventional study to test the acceptability, feasibility, and effectiveness of structured telemedicine visits to encourage lifestyle changes that will improve quality of life, disease impact, and disease activity in patients with psoriatic arthritis (PsA).

View Full Description

Full Description

The proposed trial will be embedded within clinical care. This is a 2-year interventional trial that will enroll patients with active psoriatic arthritis despite stable therapy among three centers (the University of Pennsylvania, University of Utah, and University of Oxford). The intervention employs PsOWellTM, a program that trains clinicians to utilize motivational interviewing to help patients set goals and make lifestyle/behavior changes for holistic management of psoriasis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Population: Patients with Psoriatic Arthritis

Age 18-89.
Active symptoms of PsA as defined by a PsA Impact of Disease (PsAID) questionnaire score >4 (range 0-10, 4 is the patient acceptable symptom state) or a patient global assessment of greater than 4 (scale 0-10).
Patients should be stable on therapy (i.e., not planning to switch therapy at the current visit).
Meet CASPAR criteria.
Provision of signed and dated informed consent form.
Willingness to comply with all study procedures and availability for duration of the study.
Has access to a mobile phone or other mobile device.

Exclusion Criteria:

Inability to provide informed consent.
Plan to change systemic treatment for psoriasis or PsA in the next 4-8 weeks.
PsAID score ≤4

Study is for people with:

Psoriasis

Estimated Enrollment:

87

Study ID:

NCT05631223

Recruitment Status:

Recruiting

Sponsor:

University of Pennsylvania

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

University Of Pennsylvania
Philadelphia Pennsylvania, 19104, United States More Info
Sarah Gillespie
Contact
[email protected]
Coordinator
Contact
[email protected]
Alexis Ogdie-Beatty, MD
Principal Investigator
University of Utah
Salt Lake City Utah, 84112, United States More Info
Julieanne Hall
Contact
[email protected]
Jessica Walsh, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

87

Study ID:

NCT05631223

Recruitment Status:

Recruiting

Sponsor:


University of Pennsylvania

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.